Active surveillance for brain and spinal cord tumours

Active surveillance may be a treatment option for some types of low-grade brain or spinal cord tumours. This means that your healthcare team watches your tumour closely rather than giving treatment right away. They will use tests and exams to check if the tumour is progressing or your condition is getting worse. Treatment is given when you develop symptoms or the tumour changes.

This approach helps avoid side effects that can happen with treatments such as surgery or radiation therapy. There is no evidence so far that people won’t live as long when they get active surveillance compared to other treatments. There is no evidence that active surveillance has other negative effects if or when you start treatment.

Expert review and references

  • American Cancer Society. Treating Brain and Spinal Cord Tumors in Adults. 2020: https://www.cancer.org/.
  • PDQ® Adult Treatment Editorial Board. Adult Central Nervous System Tumors Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; 2023: https://www.cancer.gov/.
  • Youngblood MW, Magill ST, Stupp R, Tsien C. Neoplasms of the central nervous system. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, [chapter 64], https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society